NCT03199846View on ClinicalTrials.gov

Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States

CompletedOBSERVATIONAL
Enrollment

650

Participants

Timeline

Start Date

October 25, 2016

Primary Completion Date

October 30, 2017

Study Completion Date

December 31, 2017

Conditions
Melanoma
Interventions
OTHER

Non-Interventional

Non-Interventional

Trial Locations (1)

07960

Local Institution, Morristown

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT03199846 - Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States | Biotech Hunter | Biotech Hunter